First advanced certification for total hip, knee replacement awarded by Joint Commission

Ohio Specialty Surgical Suites of North Canton has become the first ambulatory surgical center to earn the Joint Commission’s advanced certification for total hip and total knee replacement.

The commission’s press release lauded Ohio Specialty Surgical Suites for its “coordinated, comprehensive care” for patients undergoing joint replacement procedures after a review of orthopedic consultation, pre-operative procedures, intraoperative and post-surgical care of patients and orthopedic surgeon follow-up care.

“Since opening our doors to joint replacement surgery in 2015, Ohio Specialty Surgical Suites has performed over 300 joint replacement surgeries and we have sent these patients home the same day,” Chris Moore, RN, the center’s joint replacement coordinator. “We are honored to be recognized for this advanced certification for the high quality of care we have provided to our patients and many more to follow. We are progressive in our care of the patient as a whole. We address the patient’s entire health status well before and after surgery. Our staff is specifically trained to prepare the joint replacement patient for surgery and high quality of life after surgery. We provide advanced techniques in surgery, anesthesia and education to prepare our patients to recover quickly, yet safely just hours after surgery.”

The certification process is open to Joint Commission-accredited hospitals, ASCs and critical access hospitals. The certification depends on areas like transitions which occur through each phase of care from consultation to post-operative follow-up and educating patients on the risk factors and rehabilitation after surgery.

Applications can be requested here

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.